Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients With Cancer
Nobuyuki Katakami(Takarazuka City Hospital), Narikazu Boku(Tokyo Medical University), Koji Oda(Tokyo Metropolitan University), Yura Suzuki(Japanese Foundation For Cancer Research), Takaaki Yokota(Japanese Foundation For Cancer Research), Ken Nakata(Sakai Municipal Hospital), Masaru Narabayashi(Japanese Foundation For Cancer Research), Katsunori Shinozaki(Japanese Foundation For Cancer Research), Katsunori Tauchi(Japanese Foundation For Cancer Research)
Cited by 64
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
|Journal of Clinical Oncology|2013|632
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer
|International Journal of Clinical Oncology|2015|600
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
|The Lancet Oncology|2018|579
Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience
|Journal of Hepato-Biliary-Pancreatic Surgery|2000|396